Table 4.

Risk of bleeding after medical interventions




Carriers, event/total (%)

Noncarriers, event/total (%)

RR (CI)
Tooth extraction    
Prolonged bleeding; more than 3 h   61/228 (27)   26/219 (12)   2.3 (1.5-3.4)  
Treatment after intervention   24/228 (11)   1/219 (0.5)   23.1 (3.1-169)  
Tonsillectomy or adenotomy    
Prolonged bleeding; more than 3 h   29/123 (24)   16/122 (13)   1.8 (1.0-3.1)  
Treatment after intervention   10/123 (8)   1/122 (0.8)   9.9 (1.3-76.3)  
Operations    
Prolonged bleeding; more than 3 h   46/163 (28)   16/146 (11)   2.6 (1.5-4.3)  
Treatment; ever   16/174 (9)   6/149 (4)   2.3 (0.9-5.7)  
Blood transfusion
 
29/174 (17)
 
18/149 (12)
 
1.4 (0.8-2.4)
 



Carriers, event/total (%)

Noncarriers, event/total (%)

RR (CI)
Tooth extraction    
Prolonged bleeding; more than 3 h   61/228 (27)   26/219 (12)   2.3 (1.5-3.4)  
Treatment after intervention   24/228 (11)   1/219 (0.5)   23.1 (3.1-169)  
Tonsillectomy or adenotomy    
Prolonged bleeding; more than 3 h   29/123 (24)   16/122 (13)   1.8 (1.0-3.1)  
Treatment after intervention   10/123 (8)   1/122 (0.8)   9.9 (1.3-76.3)  
Operations    
Prolonged bleeding; more than 3 h   46/163 (28)   16/146 (11)   2.6 (1.5-4.3)  
Treatment; ever   16/174 (9)   6/149 (4)   2.3 (0.9-5.7)  
Blood transfusion
 
29/174 (17)
 
18/149 (12)
 
1.4 (0.8-2.4)
 

Participants who had been treated prior to the clinical intervention with clotting factor preparations, tranexamic acid, or desmopressin were excluded from the analysis.

Close Modal

or Create an Account

Close Modal
Close Modal